H1N1 Pandemic Virus Does Not Mutate Into 'Superbug' in UMd. Lab StudySeptember 01, 2009COLLEGE PARK, Md. - A laboratory study by University of Maryland researchers suggests that some of the worst fears about a virulent H1N1 pandemic flu season may not be realized this year, but does demonstrate the heightened communicability of the virus. Using ferrets exposed to three different viruses, the Maryland researchers found no evidence that the H1N1 pandemic variety, responsible for the so-called swine flu, combines in a lab setting with other flu strains to form a more virulent 'superbug.' Rather, the pandemic virus prevailed and out-competed the other strains, reproducing in the ferrets, on average, twice as much. The researchers believe their study is the first to examine how the pandemic virus interacts with other flu viruses. The findings are newly published in an online scientific journal designed to fast-track science research and quickly share results with other investigators, PLOS Currents. "The H1N1 pandemic virus has a clear biological advantage over the two main seasonal flu strains and all the makings of a virus fully adapted to humans," says virologist Daniel Perez, the lead researcher and program director of the University of Maryland-based Prevention and Control of Avian Influenza Coordinated Agricultural Project. "I'm not surprised to find that the pandemic virus is more infectious, simply because it's new, so hosts haven't had a chance to build immunity yet. Meanwhile, the older strains encounter resistance from hosts' immunity to them," Perez adds. Some of the animals who were infected with both the new virus and one of the more familiar seasonal viruses (H3N2) developed not only respiratory symptoms, but intestinal illness as well. Perez and his team call for additional research to see whether this kind of co-infection and multiple symptoms may account for some of the deaths attributed to the new virus. Among other research findings, the pandemic virus successfully established infections deeper in the ferret's respiratory system, including the lungs. The H1 and H3 seasonal viruses remained in the nasal passages. "Our findings underscore the need for vaccinating against the pandemic flu virus this season," Perez concludes. "The findings of this study are preliminary, but the far greater communicability of the pandemic virus serves as a clearly blinking warning light." Perez and his team used samples of the H1N1 pandemic variety from last April's initial outbreak of the so-called swine flu. The research is funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. University of Maryland |
|||||||||||||||||||||
| Related H1N1 Pandemic Current Events and H1N1 Pandemic News Articles Preventing H1N1 spread to health care workers: Dilemma, debate and confusion A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. New culprit for viral infections among elderly -- an overactive immune response Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. Mechanical ventilation for patients with lung damage don't always work as planned As more Canadians are diagnosed with H1N1 influenza infection, some will be admitted to hospital. The most severely affected may be treated in the intensive care unit (ICU) and placed on a mechanical ventilator to help them breathe while they recover from the infection. Researchers mobilizing global resources to test new treatments for severe H1N1 infection An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. H1N1 simulation modeling shows rapid vaccine rollout effective in reducing infection rates Early action, especially rapid rollout of vaccines, is extremely effective in reducing the attack rate of the H1N1 influenza virus, according to a simulation model of a pandemic outbreak reported in a new study in CMAJ. Most would refuse emergency use H1N1 vaccine or additive A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. Medical ethics experts identify, address key issues in H1N1 pandemic The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion. Was the public health response to swine flu alarmist? The public health measures taken in response to swine flu may be seen as alarmist, overly restrictive, or even unjustified. Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza Preliminary findings in ferrets suggest that the novel 2009 H1N1 influenza virus may outcompete human seasonal influenza viruses, researchers say. Avian influenza strain primes brain for Parkinson's disease At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson's disease and possibly other neurological problems later in life. More H1N1 Pandemic Current Events and H1N1 Pandemic News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||